In Re BioMarin Pharmaceutical Inc. Securities Litigation

BioMarin Pharmaceutical Securities Litigation

This official website is maintained by the Notice Administrator supervised by Lead Counsel in the action entitled In re BioMarin Pharmaceutical Inc. Securities Litigation, Case 3:20-cv-06719-WHO (N.D. Cal.) (the “Action”) pending in the United States District Court for the Northern District of California.

Notice

Please use the link below to view a full copy of the Notice.

Notice of (I) Pendency of Class Action and Proposed Settlement; (II) Settlement Hearing; and (III) Motion for Attorneys’ Fees and Litigation Expenses (“Notice”)

Note: These documents are in PDF format. To view the
documents, you will need Adobe Acrobat Reader on your computer or other internet-enabled device.